• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种新型二级表型筛选方法,以在分枝杆菌蛋白质合成流程中识别有效药物。

Development of a novel secondary phenotypic screen to identify hits within the mycobacterial protein synthesis pipeline.

作者信息

Burke Christopher, Jankute Monika, Moynihan Patrick, Gonzalez Del Rio Ruben, Li Xiaojun, Esquivias Jorge, Lelièvre Joël, Cox Jonathan A G, Sacchettini James, Besra Gurdyal S

机构信息

Institute of Microbiology and Infection School of Biosciences University of Birmingham Birmingham UK.

Diseases of the Developing World GlaxoSmithKline Tres Cantos Madrid Spain.

出版信息

FASEB Bioadv. 2020 Aug 20;2(10):600-612. doi: 10.1096/fba.2020-00022. eCollection 2020 Oct.

DOI:10.1096/fba.2020-00022
PMID:33089076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7566049/
Abstract

BACKGROUND

Whole-cell phenotypic screening is the driving force behind modern anti-tubercular drug discovery efforts. Focus has shifted from screening for bactericidal scaffolds to screens incorporating target deconvolution. Target-based screening aims to direct drug discovery toward known effective targets and avoid investing resources into unproductive lines of enquiry. The protein synthesis pipeline, including RNA polymerase and the ribosome, is a clinically proven target in . Screening for new hits of this effective target pathway is an invaluable tool in the drug discovery arsenal.

METHODS

Using . H37Rv augmented with anhydrotetracycline-inducible expression of mCherry, a phenotypic screen was developed for the identification of protein synthesis inhibitors in a medium throughput screening format.

RESULTS

The assay was validated using known inhibitors of protein synthesis to show a dose-dependent reduction in mCherry fluorescence. This was expanded to a proprietary screen of hypothetical protein synthesis hits and modified to include quantitative viability measurement of cells using resazurin.

CONCLUSION

Following the success of the proprietary screen, a larger scale screen of the GlaxoSmithKline anti-tubercular library containing 2799 compounds was conducted. Combined single shot and dose-response screening yielded 18 hits, 0.64% of all screened compounds.

摘要

背景

全细胞表型筛选是现代抗结核药物研发工作的驱动力。重点已从筛选杀菌性骨架转向纳入靶点反卷积的筛选。基于靶点的筛选旨在将药物研发导向已知的有效靶点,避免将资源投入到无成效的研究方向。包括RNA聚合酶和核糖体在内的蛋白质合成途径是临床上已证实的靶点。筛选该有效靶点途径的新命中物是药物研发武器库中的一项宝贵工具。

方法

利用经脱水四环素诱导表达mCherry增强的H37Rv,开发了一种表型筛选方法,用于以中等通量筛选形式鉴定蛋白质合成抑制剂。

结果

使用已知的蛋白质合成抑制剂对该测定法进行验证,结果显示mCherry荧光呈剂量依赖性降低。这一方法扩展到对假设的蛋白质合成命中物进行专有筛选,并进行修改以包括使用刃天青对细胞进行定量活力测定。

结论

在专有筛选取得成功之后,对包含2799种化合物的葛兰素史克抗结核文库进行了更大规模的筛选。单次筛选和剂量反应筛选相结合产生了18个命中物,占所有筛选化合物的0.64%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/28610ccc629a/FBA2-2-600-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/c9787db96b15/FBA2-2-600-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/2b93fcc0148e/FBA2-2-600-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/445063066c92/FBA2-2-600-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/7ff9fd1dcd07/FBA2-2-600-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/84b55a4985f5/FBA2-2-600-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/58ab64b1a5b7/FBA2-2-600-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/28610ccc629a/FBA2-2-600-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/c9787db96b15/FBA2-2-600-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/2b93fcc0148e/FBA2-2-600-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/445063066c92/FBA2-2-600-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/7ff9fd1dcd07/FBA2-2-600-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/84b55a4985f5/FBA2-2-600-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/58ab64b1a5b7/FBA2-2-600-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d39e/7566049/28610ccc629a/FBA2-2-600-g007.jpg

相似文献

1
Development of a novel secondary phenotypic screen to identify hits within the mycobacterial protein synthesis pipeline.开发一种新型二级表型筛选方法,以在分枝杆菌蛋白质合成流程中识别有效药物。
FASEB Bioadv. 2020 Aug 20;2(10):600-612. doi: 10.1096/fba.2020-00022. eCollection 2020 Oct.
2
Development of a whole-cell high-throughput phenotypic screen to identify inhibitors of mycobacterial amino acid biosynthesis.开发一种全细胞高通量表型筛选方法以鉴定分枝杆菌氨基酸生物合成抑制剂。
FASEB Bioadv. 2019 Jan 22;1(4):246-254. doi: 10.1096/fba.2018-00048. eCollection 2019 Apr.
3
Fragment-Based Whole Cell Screen Delivers Hits against M. tuberculosis and Non-tuberculous Mycobacteria.基于片段的全细胞筛选获得针对结核分枝杆菌和非结核分枝杆菌的活性化合物。
Front Microbiol. 2016 Sep 7;7:1392. doi: 10.3389/fmicb.2016.01392. eCollection 2016.
4
Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents.结核分枝杆菌全细胞筛选物作为潜在抗结核药物的开发。
J Med Chem. 2013 Oct 24;56(20):7755-60. doi: 10.1021/jm400381v. Epub 2013 Sep 23.
5
A high-throughput target-based screening approach for the identification and assessment of mycothione reductase inhibitors.一种基于高通量筛选的方法,用于鉴定和评估 硫氧还蛋白还原酶抑制剂。
Microbiol Spectr. 2024 Mar 5;12(3):e0372323. doi: 10.1128/spectrum.03723-23. Epub 2024 Feb 5.
6
Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery.疟疾和结核病药物发现中的综合线索生成和靶标鉴定的新见解。
Acc Chem Res. 2017 Jul 18;50(7):1606-1616. doi: 10.1021/acs.accounts.6b00631. Epub 2017 Jun 21.
7
Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.抗结核化合物库筛选鉴定出新型结核分枝杆菌ATP合酶抑制剂。
Tuberculosis (Edinb). 2018 Jan;108:56-63. doi: 10.1016/j.tube.2017.10.008. Epub 2017 Oct 25.
8
Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen.基于靶标的高通量表型筛选鉴定结核分枝杆菌 GuaB2 的新型抑制剂。
Sci Rep. 2016 Dec 16;6:38986. doi: 10.1038/srep38986.
9
Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.勘误:利用幼苗浸没法高通量鉴定番茄对丁香假单胞菌 pv.番茄的抗性。
J Vis Exp. 2023 Oct 18(200). doi: 10.3791/6576.
10
Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.新型苯并噻唑衍生物作为抗结核药物的合成与结构解析:用于可能靶点识别的计算机模拟筛选
Med Chem. 2019;15(3):311-326. doi: 10.2174/1573406414666180703121815.

引用本文的文献

1
"Upcycling" known molecules and targets for drug-resistant TB.将已知的耐药结核病药物分子和靶点进行“升级利用”。
Front Cell Infect Microbiol. 2022 Oct 6;12:1029044. doi: 10.3389/fcimb.2022.1029044. eCollection 2022.
2
Elucidating the Antimycobacterial Mechanism of Action of Ciprofloxacin Using Metabolomics.利用代谢组学阐明环丙沙星的抗分枝杆菌作用机制
Microorganisms. 2021 May 28;9(6):1158. doi: 10.3390/microorganisms9061158.

本文引用的文献

1
Development of a whole-cell high-throughput phenotypic screen to identify inhibitors of mycobacterial amino acid biosynthesis.开发一种全细胞高通量表型筛选方法以鉴定分枝杆菌氨基酸生物合成抑制剂。
FASEB Bioadv. 2019 Jan 22;1(4):246-254. doi: 10.1096/fba.2018-00048. eCollection 2019 Apr.
2
Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach.通过整合全细胞基于靶标的方法鉴定和表征结核分枝杆菌天冬氨酰-tRNA 合成酶抑制剂。
Sci Rep. 2018 Aug 23;8(1):12664. doi: 10.1038/s41598-018-31157-3.
3
Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656).
一种强效且特异性的结核分枝杆菌亮氨酰 - tRNA合成酶抑制剂的发现:(S)-3-(氨甲基)-4-氯-7-(2-羟基乙氧基)苯并[c][1,2]氧杂硼杂环戊烷-1(3H)-醇(GSK656)。
J Med Chem. 2017 Oct 12;60(19):8011-8026. doi: 10.1021/acs.jmedchem.7b00631. Epub 2017 Sep 27.
4
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface.靶向于亚基间界面抑制分枝杆菌色氨酸合酶。
Sci Rep. 2017 Aug 25;7(1):9430. doi: 10.1038/s41598-017-09642-y.
5
Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition.结核分枝杆菌转录及转录抑制的结构基础
Mol Cell. 2017 Apr 20;66(2):169-179.e8. doi: 10.1016/j.molcel.2017.03.001. Epub 2017 Apr 6.
6
Identification of KasA as the cellular target of an anti-tubercular scaffold.鉴定 KasA 为抗结核支架的细胞靶标。
Nat Commun. 2016 Sep 1;7:12581. doi: 10.1038/ncomms12581.
7
Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.用于结核病药物发现中快速作用机制评估的生物发光报告基因
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6748-6757. doi: 10.1128/AAC.01178-16. Print 2016 Nov.
8
THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria.THPP 靶标分配揭示 EchA6 是分枝杆菌中必需的脂肪酸穿梭蛋白。
Nat Microbiol. 2016 Jan 18;1:15006. doi: 10.1038/nmicrobiol.2015.6.
9
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.发现靶向亮氨酰 - tRNA合成酶的新型结核分枝杆菌口服蛋白质合成抑制剂。
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6271-80. doi: 10.1128/AAC.01339-16. Print 2016 Oct.
10
Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery.为开源抗结核药物研发发布50种新型类药物化合物及其计算靶点预测。
PLoS One. 2015 Dec 7;10(12):e0142293. doi: 10.1371/journal.pone.0142293. eCollection 2015.